Serum C-reactive protein levels in pre-dialysis chronic kidney disease patientsin southern Nigeria
- PMID: 27605722
- PMCID: PMC4994480
- DOI: 10.4314/gmj.v50i1.5
Serum C-reactive protein levels in pre-dialysis chronic kidney disease patientsin southern Nigeria
Abstract
Background: Cardiovascular disease is the major cause of hospitalization and mortality in chronic kidney disease (CKD). C-reactive protein (CRP) is a marker of cardiovascular disease and predictor of mortality in CKD patients. CKD patients with elevated CRP should be identified early with institution of measures to treat cardiovascular risk factors in order to reduce attendant mortality.
Aims: Determination of serum CRP levels in CKD patients and associated factors.
Methods: This was a case-control study involving 80 consecutive CKD patients and 40 control subjects without CKD. Data obtained from participants included demographics, body mass index (BMI), and aetiology of CKD. Serum CRP levels, albumin, creatinine and lipid profile were determined. Cases and controls were compared. P values <0.05 were taken as significant.
Results: The mean age of the CKD subjects was 49.09±16.85 years. The median CRP value was significantly higher in the CKD group compared to controls (p=<0.001). Low, average and high cardiovascular event risk according to CRP values were present in 51(63.8%), 13(16.2%) and 16(20%) of the CKD patients respectively. Cardiovascular event risk was significantly higher in CKD subjects (p=<0.001). Serum creatinine, BMI, triglyceride and atherogenic index of plasma correlated positively with CRP. Estimated glomerular filtration rate (eGFR), high density lipoprotein-cholesterol and albumin correlated negatively with CRP. Elevated serum CRP was significantly predicted by low eGFR and high BMI on multivariate analysis.
Conclusion: Chronic kidney disease patients have increased cardiovascular event risk. Interventions aimed at reducing weight and treating dyslipidaemia should be instituted early in order to reduce this risk.
Keywords: C-reactive protein; Nigeria; chronic kidney disease.
Conflict of interest statement
Conflicts of Interest: None declared
Similar articles
-
Lipid profile in pre-dialysis chronic kidney disease patients in southern Nigeria.Ghana Med J. 2016 Mar;50(1):44-9. doi: 10.4314/gmj.v50i1.7. Ghana Med J. 2016. PMID: 27605724 Free PMC article.
-
The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.Lipids Health Dis. 2015 Apr 16;14:29. doi: 10.1186/s12944-015-0031-4. Lipids Health Dis. 2015. PMID: 25885289 Free PMC article.
-
Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.Clin J Am Soc Nephrol. 2020 Jan 7;15(1):47-60. doi: 10.2215/CJN.07320619. Epub 2019 Dec 12. Clin J Am Soc Nephrol. 2020. PMID: 31831577 Free PMC article.
-
Current Understanding of the Relationship of HDL Composition, Structure and Function to Their Cardioprotective Properties in Chronic Kidney Disease.Biomolecules. 2020 Sep 21;10(9):1348. doi: 10.3390/biom10091348. Biomolecules. 2020. PMID: 32967334 Free PMC article. Review.
-
Dietary Lipids and Dyslipidemia in Chronic Kidney Disease.Nutrients. 2021 Sep 9;13(9):3138. doi: 10.3390/nu13093138. Nutrients. 2021. PMID: 34579015 Free PMC article. Review.
Cited by
-
Impact of the Nutrition-Inflammation Status on the Functionality of Patients with Chronic Kidney Disease.Nutrients. 2022 Nov 10;14(22):4745. doi: 10.3390/nu14224745. Nutrients. 2022. PMID: 36432432 Free PMC article.
-
Pathogenesis of Sarcopenia in Chronic Kidney Disease-The Role of Inflammation, Metabolic Dysregulation, Gut Dysbiosis, and microRNA.Int J Mol Sci. 2024 Aug 3;25(15):8474. doi: 10.3390/ijms25158474. Int J Mol Sci. 2024. PMID: 39126043 Free PMC article. Review.
-
Dietary Patterns, Kidney Function, and Sarcopenia in Chronic Kidney Disease.Nutrients. 2025 Jan 23;17(3):404. doi: 10.3390/nu17030404. Nutrients. 2025. PMID: 39940262 Free PMC article. Review.
-
The effect of exercise training in people with pre-dialysis chronic kidney disease: a systematic review with meta-analysis.J Nephrol. 2024 Nov;37(8):2063-2098. doi: 10.1007/s40620-024-02081-9. Epub 2024 Oct 17. J Nephrol. 2024. PMID: 39417982 Free PMC article.
-
The atherogenic index of plasma is a strong and independent predictor for coronary artery disease in the Chinese Han population.Medicine (Baltimore). 2017 Sep;96(37):e8058. doi: 10.1097/MD.0000000000008058. Medicine (Baltimore). 2017. PMID: 28906400 Free PMC article.
References
-
- US Renal Data System, author. 2002 Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2002.
-
- Locatelli F, Marcelli D, Conte F, D'Amico M, Del Vecchio L, Limido A, et al. Cardiovascular disease in chronic renal failure: the challenge continues. Nephrol Dial Transplant. 2000;15(Suppl 5):69–80. - PubMed
-
- Foley RN, Parfey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;339:841–843. - PubMed
-
- Locatelli F, Marcelli D, Conte F, Del Vecchio, Limido A, Malberti F, et al. Patients selection affects end stage renal disease outcome comparison. Kidney Int. 2000;57(suppl 74):94–99.
-
- Arici M, Walls J. End stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link? Kidney Int. 2001;59:407–417. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous